Improving Health Outcomes for Black Women and Girls With Disabilities
By Megan Buckles and Mia Ives-Rublee,
Center for American Progress
| 02. 15. 2022
Photo licensed for reuse under CC BY 4.0
Studies show that people with disabilities are more likely than people without disabilities to report having poorer health and less access to adequate health care.1 This is especially true for women and girls of color with disabilities, who face inequalities because of their disability status, race, and gender.2 The systemic and structural barriers faced by Black disabled women and girls in the health care system stem from a legacy of slavery, ongoing anti-Black racism, and ableism.
The COVID-19 pandemic exposed and exacerbated those inequalities. According to the Centers for Disease Control and Prevention, Black Americans are dying from COVID-19 at nearly twice the rate of white Americans and have hospitalization rates that are nearly three times higher.3 People with disabilities are also disproportionately contracting and dying from COVID-19.4
Data are more limited for people with intersecting identities. Specifically, there are insufficient data on the impact of COVID-19 on women—and even less on Black women and still less for Black women with disabilities. According to a study from January 2021,5 U.S...
Related Articles
By Matt Novak, Gizmodo | 07.23.2025
Robert F. Kennedy Jr., the Secretary of Health and Human Services, has made a big push to get agencies like the Food and Drug Administration to use generative artificial intelligence tools. In fact, Kennedy recently told Tucker Carlson that AI...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...